-
公开(公告)号:US20240350701A1
公开(公告)日:2024-10-24
申请号:US18756729
申请日:2024-06-27
Applicant: Arsenal Medical, Inc.
Inventor: Jeffrey Groom , Craig Wiltsey , Quynh Pham , Nikhita Mansukhani , Courtney Guertin , Lee Core , Upma Sharma
CPC classification number: A61L24/06 , A61K47/02 , A61K47/34 , A61K49/04 , A61K49/0409 , A61L24/0021 , A61L24/02 , A61L24/043 , A61L24/046 , C08L83/04 , A61L2400/06 , A61L2430/36
Abstract: The present disclosure pertains to crosslinkable compositions and systems as well as methods for forming crosslinked compositions in situ, including the use of the same for embolizing vasculature including the neurovasculature within a patient, among many other uses.
-
公开(公告)号:US20240350700A1
公开(公告)日:2024-10-24
申请号:US18756702
申请日:2024-06-27
Applicant: Arsenal Medical, Inc.
Inventor: Jeffrey Groom , Craig Wiltsey , Quynh Pham , Nikhita Mansukhani , Courtney Guertin , Lee Core , Upma Sharma
CPC classification number: A61L24/06 , A61K47/02 , A61K47/34 , A61K49/04 , A61K49/0409 , A61L24/0021 , A61L24/02 , A61L24/043 , A61L24/046 , C08L83/04 , A61L2400/06 , A61L2430/36
Abstract: The present disclosure pertains to crosslinkable compositions and systems as well as methods for forming crosslinked compositions in situ, including the use of the same for embolizing vasculature including the neurovasculature within a patient, among many other uses.
-
公开(公告)号:US11992576B2
公开(公告)日:2024-05-28
申请号:US17342945
申请日:2021-06-09
Applicant: Arsenal Medical, Inc.
Inventor: Jeffrey Groom , Craig Wiltsey , Quynh Pham , Nikhita Mansukhani , Courtney Guertin , Lee Core , Upma Sharma
CPC classification number: A61L24/06 , A61K47/02 , A61K47/34 , A61K49/04 , A61K49/0409 , A61L24/0021 , A61L24/02 , A61L24/043 , A61L24/046 , C08L83/04 , A61L2400/06 , A61L2430/36
Abstract: The present disclosure pertains to crosslinkable compositions and systems as well as methods for forming crosslinked compositions in situ, including the use of the same for embolizing vasculature including the neurovasculature within a patient, among many other uses.
-
公开(公告)号:US11786642B2
公开(公告)日:2023-10-17
申请号:US16987754
申请日:2020-08-07
Applicant: Arsenal Medical Inc.
Inventor: Upma Sharma , Irina Gitlin , Gregory T. Zugates , Adam Rago , Parisa Zamiri , Rany Busold , Toby Freyman , Robert J. Caulkins , Quynh P. Pham , Changcheng You , Jeffrey D. Carbeck
IPC: A61F2/02 , A61L31/06 , A61J1/20 , A61L27/18 , A61L27/56 , A61L27/58 , A61L31/14 , A61M37/00 , A61B17/12 , C08L63/00
CPC classification number: A61L31/06 , A61B17/12031 , A61B17/12163 , A61B17/12186 , A61J1/2093 , A61L27/18 , A61L27/56 , A61L27/58 , A61L31/141 , A61L31/146 , A61L31/148 , A61M37/00 , C08L63/00 , A61B2017/12004 , A61L2400/04 , A61L2400/06 , A61L2400/18 , A61L27/18 , C08L63/00 , A61L27/18 , C08L67/04 , A61L31/06 , C08L67/04
Abstract: Systems and methods related to polymer foams are generally described. Some embodiments relate to compositions and methods for the preparation of polymer foams, and methods for using the polymer foams. The polymer foams can be applied to a body cavity and placed in contact with, for example, tissue, injured tissue, internal organs, etc. In some embodiments, the polymer foams can be formed within a body cavity (i.e., in situ foam formation). In addition, the foamed polymers may be capable of exerting a pressure on an internal surface of a body cavity and preventing or limiting movement of a bodily fluid (e.g., blood, etc.).
-
公开(公告)号:US10980920B2
公开(公告)日:2021-04-20
申请号:US15923003
申请日:2018-03-16
Applicant: ARSENAL MEDICAL, INC.
Inventor: Upma Sharma , Irina Gitlin , Gregory T. Zugates , Adam Rago , Parisa Zamiri , Rany Busold , Robert J. Caulkins , Toby Freyman , Quynh Pham , Changcheng You , Jeffrey Carbeck
IPC: A61F2/02 , A61L31/06 , A61J1/20 , A61L27/18 , A61L27/56 , A61L27/58 , A61L31/14 , A61M37/00 , A61B17/12 , C08L63/00
Abstract: Systems and methods related to polymer foams are generally described. Some embodiments relate to compositions and methods for the preparation of polymer foams, and methods for using the polymer foams. The polymer foams can be applied to a body cavity and placed in contact with, for example, tissue, injured tissue, internal organs, etc. In some embodiments, the polymer foams can be formed within a body cavity (i.e., in situ foam formation). In addition, the foamed polymers may be capable of exerting a pressure on an internal surface of a body cavity and preventing or limiting movement of a bodily fluid (e.g., blood, etc.).
-
公开(公告)号:US20180256774A9
公开(公告)日:2018-09-13
申请号:US15355397
申请日:2016-11-18
Applicant: ARSENAL MEDICAL, INC.
Inventor: Adam Rago , John Marini , Gregory T. Zugates , Marc Helmick , Upma Sharma
CPC classification number: A61L24/0036 , A61L24/06
Abstract: Systems, methods and kits for treating hemorrhages within cavities are provided. The methods utilize the application of a rapid spike of pressure to the closed cavity, followed by a steady state pressure or pressures.
-
公开(公告)号:US10052107B2
公开(公告)日:2018-08-21
申请号:US14212930
申请日:2014-03-14
Applicant: ARSENAL MEDICAL, INC.
Inventor: Rany Busold , John Marini , Upma Sharma , Adam Rago , Jennifer Mortensen , Joseph Lomakin , Gregory T. Zugates , Janet Komatsu , Jeffrey Groom, III
CPC classification number: A61B17/12118 , A61B17/12186 , A61B17/1219 , A61B17/12195 , A61B2017/1205 , A61B2217/005 , A61F2/07 , A61F2/95 , A61F2002/077 , A61M25/0067 , A61M25/007 , A61M25/0074 , A61M25/10 , A61M25/1006 , A61M2025/0004 , A61M2025/0078 , A61M2025/0175
Abstract: Systems and method for treating aneurysms are provided which utilize formulations that form polymer foams in situ. The formulations generally have a buoyancy greater than or less than blood, and either float to the top of the aneurysm and foam from the top down or sink to the bottom and foam from the bottom up.
-
公开(公告)号:US20180028189A1
公开(公告)日:2018-02-01
申请号:US15729993
申请日:2017-10-11
Applicant: ARSENAL MEDICAL, INC.
Inventor: Adam Rago , John Marini , Gregory T. Zugates , Marc Helmick , Upma Sharma
CPC classification number: A61B17/12 , A61B2017/12004 , A61L24/0036 , A61L24/046 , A61L2400/04 , A61M13/003 , A61M2205/3341 , A61M2205/3344 , A61M2210/1021 , A61M2210/12 , C08L75/04
Abstract: Systems, methods and kits for treating hemorrhages within cavities are provided. The methods utilize the application of a rapid spike of pressure to the closed cavity, followed by a steady state pressure or pressures.
-
公开(公告)号:US09044580B2
公开(公告)日:2015-06-02
申请号:US13815910
申请日:2013-03-15
Applicant: Arsenal Medical, Inc.
Inventor: Toby Freyman , Joseph Lomakin , John Marini , Jennifer Mortensen , Adam Rago , Rany Busold , Upma Sharma , Gregory T. Zugates
IPC: A61F2/02 , A61M37/00 , A61L31/06 , A61L31/12 , A61L31/14 , A61L24/00 , A61L24/04 , A61F2/07 , A61B17/12 , A61J1/20 , A61F2/06
CPC classification number: A61B17/12181 , A61B17/12113 , A61B17/12118 , A61B17/1214 , A61B2017/1205 , A61F2/07 , A61F2002/065 , A61F2002/077 , A61F2210/0085 , A61J1/2093 , A61L24/0036 , A61L24/0089 , A61L24/046 , A61L31/06 , A61L31/128 , A61L31/146 , A61L2300/60 , A61L2400/06 , A61M37/00 , C08L67/04 , C08L83/04
Abstract: Systems, methods and kits relating to in-situ forming polymer foams for the treatment of aneurysms or fluid filled spaces are disclosed. The systems include an insertable medical device and an in-situ forming foam of lava like materials with a fast forming outer skin and a slower hardening interior that is formed from a one-, two- or multi-part formulation. When used to treat an aneurysm, the foam is placed into contact with at least a portion of an exterior surface of the medical device and/or the tissue surface of the aneurysm.
Abstract translation: 公开了与原位形成聚合物泡沫相关的用于治疗动脉瘤或填充液体的空间的系统,方法和试剂盒。 这些系统包括可插入的医疗装置和具有快速成形外皮的熔岩状材料的原位成形泡沫体,以及由一部分,两部分或多部分制剂形成的较慢的硬化内部。 当用于治疗动脉瘤时,将泡沫放置成与医疗装置的外表面的至少一部分和/或动脉瘤的组织表面接触。
-
公开(公告)号:US20250025600A1
公开(公告)日:2025-01-23
申请号:US18910397
申请日:2024-10-09
Applicant: Arsenal Medical, Inc.
Inventor: Jeffrey Groom , Craig Wiltsey , Quynh Pham , Nikhita Mansukhani , Courtney Guertin , Lee Core , Upma Sharma
Abstract: The present disclosure pertains to crosslinkable compositions and systems as well as methods for forming crosslinked compositions in situ, including the use of the same for embolizing vasculature including the neurovasculature within a patient, among many other uses.
-
-
-
-
-
-
-
-
-